Aesthetic/Cosmetic Lasers Market Value

October 28, 2016

According to a new market research report “Aesthetic/Cosmetic LasersMarket by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye),Multiplatform), by Application (Acne, Scars, Tattoo Removal, Varicose Veins), by End User (Hospitals, Medical Spa, Private clinics) – Forecasts to 2021” published by MarketsandMarkets, The global market is projected to reach USD 1,132.7 Million by 2021 from USD 697.6 Million in 2016, growing at a CAGR of 10.2% during the forecast period.
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, currentmarket trends, and strategies impacting the Aesthetic/Cosmetic Lasers Market along with the estimates and forecasts of the revenue. Growth in the adoption of non-invasive cosmetic procedures, changing lifestyle and increasing disposable income, advancements in technology, and rising medical tourism are the major drivers of the Aesthetic/Cosmetic Lasers Market. However, lack of reimbursement will restrain the growth of this market.
The Aesthetic/Cosmetic Lasers Market is segmented on the basis of type, application, end user, and region. Based on type, the aesthetic/cosmetic lasers type market is categorized into standalone lasers and multiplatform lasers. In this market, multiplatform lasers form the fastest-growing segment as they provide scalable and upgradeable hybrid systems that can treat multiple indications. Furthermore, the standalone lasers market is divided into carbon dioxide (CO2) lasers, Er:YAG lasers, diode lasers, pulsed dye lasers, nd:YAG lasers, alexandrite lasers, and other standalone lasers (argon, ruby, krypton lasers, and erbium:glass lasers).
Read More >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications
    • ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s